ROCKET PHARMACEUTICALS, INC.
RCKTCIK 0001281895 · Every Form 4 filed by insiders at this issuer.
Filings
15
Latest Mar 25, 2024
Unique insiders
6
Showing
15 of 15
Page 1
Top insiders
Most active reporters at ROCKET PHARMACEUTICALS, INC.
| Name | Roles | Filings |
|---|---|---|
| Militello John | Officer | 6 |
| Wilson Martin | Officer | 3 |
| Patel Kinnari | Officer | 2 |
| Shah Gaurav | OfficerDirector | 2 |
| Makker Gotham | Director | 1 |
| White Mark Andrew | Officer | 1 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | Militello John See Remarks | S | 2,490 | $28.104 | $69,979 | |
| Mar 25, 2024 | Makker Gotham Director | S | 274,000 | $28.4341 | $7,790,943 | |
| Mar 4, 2024 | Wilson Martin General Counsel | S | 4,100 | $29.331 | $120,257 | |
| Mar 4, 2024 | Militello John See Remarks | S | 10,000 | $29.845 | $298,450 | |
| Feb 21, 2024 | Shah Gaurav CEO · Director | S | 20,272 | $29.838 | $604,876 | |
| Feb 21, 2024 | White Mark Andrew Chief Medical Officer | A | 11,096 | $0.00 | $0 | |
| Feb 21, 2024 | Militello John See Remarks | S | 3,238 | $29.838 | $96,615 | |
| Feb 21, 2024 | Patel Kinnari See Remarks | S | 7,132 | $29.838 | $212,805 | |
| Feb 21, 2024 | Wilson Martin General Counsel | S | 3,576 | $29.838 | $106,701 | |
| Feb 16, 2024 | Militello John See Remarks | M | 6,274 | $0.00 | $0 | |
| Feb 16, 2024 | Patel Kinnari See Remarks | M | 26,189 | $0.00 | $0 | |
| Feb 16, 2024 | Shah Gaurav CEO · Director | M | 46,828 | $0.00 | $0 | |
| Feb 16, 2024 | Wilson Martin General Counsel | M | 9,712 | $0.00 | $0 | |
| Jan 23, 2024 | Militello John See Remarks | S | 638 | $27.203 | $17,356 | |
| Jan 22, 2024 | Militello John See Remarks | M | 1,586 | $0.00 | $0 |
Showing 1–15 of 15
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.